Article Information
History
- October 20, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Ashenafi S. Cherkos1,*,
- Sylvia M. LaCourse2,3,4,
- Daniel A. Enquobahrie2,
- Jaclyn N. Escudero4,
- Jerphason Mecha5,
- Daniel Matemo6,
- John Kinuthia6,7 and
- Grace John-Stewart2,3,4,8
- 1Biostatistics and Epidemiology Department, School of Public Health, University of North Texas Health Science Center, Fort Worth, Texas, USA
- 2Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, USA
- 3Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA
- 4Department of Global Health, School of Public Health, University of Washington, Seattle, Washington, USA
- 5Centre for Respiratory Diseases Research, Kenya Medical Research Institute, Nairobi, Kenya
- 6Medical Research Department, Kenyatta National Hospital, Nairobi, Kenya
- 7Department of Obstetrics and Gynaecology, Kenyatta National Hospital, Nairobi, Kenya
- 8Department of Pediatrics, University of Washington, Seattle, Washington, USA
- ↵*Corresponding author: Ashenafi S Cherkos, PhD, MPH, MPH/MCH Assistant Professor, Biostatistics and Epidemiology Department School of Public Health, University of North Texas Health Science Center at Fort Worth 3500 Camp Bowie Blvd, Fort Worth, TX 76107 | +1 8177350487 | Ashenafi.Cherkos{at}unthsc.edu
Posted October 20, 2023.
Isoniazid preventive therapy during infancy does not adversely effect growth among HIV-exposed uninfected children: secondary analysis of data from a randomized controlled trial
